Sports

India’s Loss in the Semi-Finals Cost Punters Rs. 1000 Crore

Published

6 years ago

July 13, 2019

The satta market suffered a great loss when the team India lost in the semi finals of ICC World Cup. And the loss of the favourite Indian team led to the loss of punters as well. India lost to New Zealand in the semi final. Many hoped that India’s win will help their pockets, but they bled dry.

India is out of the world cup, as it lost the knock out match to New Zealand. And many who betted on India suffered a huge loss. A betting insider told the FPJ that more than 90% of the bets were riding on India. But they suffered a loss of Rs. 1000 crore. And around the world, the loss was almost the double.

New Zealand had a slow start, and the dismal batting pitch did not give them much room to bat. Seeing this, many betted on their favourite team, India. The rate for India was Rs. 4.35. And on the other hand, for New Zealand it was Rs. 49.

Many assumed that Black caps were losers. But surprisingly, their bowling took India by surprise. And the tables turned when top three batsmen of India left the crease too early. Rohit Sharma, Virat Kohli and KL Rahul got dismissed early. And as per Satta king, even after this, many punters took chances by seeing the partnership of Dhoni and Jadeja.

India’s score was 200/6 when Dhoni and Jadeja were on crease. But after Dhoni’s run out, the stadium went quiet with disappointment. And the silence was a defeat. New Zealand bounced back in the last two overs and towards the fag end India lost wickets.

Punters who planned on having a big party after the win cancelled the bashes after huge loses. One of the punters Rajveer Singh lost 10 crores which he won from India’s successive win. He said – “Even in session to session bidding, punters lost huge amounts as they had placed bets on Dhoni-Jadeja partnership which was in top form during the last session.”

Sports

Professional basketball player Kévin Noulowe is close to finalizing a million-dollar sponsorship deal with the Bioscience Stem Cell Institute of Dubai

Published

2 weeks ago

February 27, 2025

Jonathan Grilli

Kévin Noulowe, a 6’10” professional basketball player, is close to finalizing a million-dollar sponsorship deal with the Bioscience Stem Cell Institute of Dubai, a partnership that could redefine the way athletes and individuals suffering from chronic pain approach healing and recovery.

The star basketball player is known for his athleticism, strength, and dominance on the court but is also known for having to battle injuries throughout his career. Noulowe is turning his attention to regenerative medicine, advocating for stem cell therapy as a breakthrough alternative to invasive surgeries and prolonged rehabilitation. With his towering presence in the sports world, Noulowe aims to bring awareness to the transformative potential of stem cell treatments, particularly for athletes, aging individuals, and those struggling with debilitating conditions.

Stem cell therapy, a rapidly advancing field of regenerative medicine, has gained attention for its ability to repair damaged tissues, accelerate healing, and reduce inflammation without the risks and downtime associated with traditional surgeries. Noulowe, who has seen firsthand how injuries can impact a player’s career, believes this treatment could offer a game-changing solution for athletes looking to recover faster and stay in peak condition.

Beyond the world of sports, Noulowe envisions a broader impact. His partnership with the Dubai-based stem cell institute is driven by a mission to help people across all walks of life—newborns, women, the elderly, and those suffering from chronic pain—access cutting-edge medical advancements that have the potential to restore mobility and improve quality of life.

The deal, while not yet officially signed, is in its final stages, with both parties working toward an agreement that will see Noulowe leverage his platform to promote stem cell awareness on a global scale. His advocacy comes at a time when regenerative medicine is gaining traction as a viable alternative to conventional treatments, with research showing promising results in pain management, injury recovery, and long-term health improvement.

For professional athletes, the implications are significant. Instead of relying on surgeries that can sideline careers and come with long-term consequences, players could turn to regenerative treatments that offer quicker recovery and potentially longer playing careers. Noulowe sees this as an opportunity to introduce a new era in sports medicine, where cutting-edge treatments replace outdated methods of rehabilitation.

While the details of the partnership are still being finalized, Noulowe remains committed to raising awareness and making regenerative medicine more accessible. His vision extends beyond basketball, as he seeks to create a lasting impact on how people worldwide approach healing and recovery.

As discussions near completion, anticipation is growing around what this collaboration could mean for the future of stem cell therapy in both the medical and athletic communities. Noulowe’s influence, combined with scientific advancements in regenerative medicine, has the potential to change the way injuries and chronic pain are treated—ushering in a new frontier of healing.